A team including CREDIT CRE researchers have recently published a paper on the potential for repurposing the drug trimetazidine for the treatment of bipolar depression.
Read the full paper here: Use of a gene expression signature to identify trimetazidine for repurposing to treat bipolar depression – PubMed (nih.gov)
